Otsuka Pharmaceutical Co., Ltd. et al v. Zenara Pharma Private Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 7, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (394 in 1:19-cv-01938-LPS, 11 in 1:20-cv-01599-LPS) STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Zenara) filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 12/6/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01599-LPS (ntl) |
| Dec 7, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 19-1938-LPS. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 19-1938-LPS ONLY. (ntl) |
| Nov 24, 2021 | 11 | Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Zenara), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) |
| Jan 14, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Denise Main, Erin M. Sommers, C. Collette Corser, Tyler B. Latcham for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01287-LPS et al.(kmd) |
| Jan 6, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Kenneth S. Canfield and Dmitry V. Shelhoff for Biophore India Pharmaceuticals Private Ltd. and Zenara Pharma Private Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Jan 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:20-cv-01365-LPS, 8 in 1:20-cv-01287-LPS, 13 in 1:20-cv-01296-LPS, 9 in 1:20-cv-01599-LPS, 7 in 1:20-cv-01428-LPS, 12 in 1:20-cv-01423-LPS, 11 in 1:20-cv-01335-LPS, 10 in 1:20-cv-01295-LPS, 7 in 1:20-cv-01581-LPS, 7 in 1:20-cv-01502-LPS, 7 in 1:20-cv-01763-LPS, 10 in 1:20-cv-01297-LPS, 11 in 1:20-cv-01332-LPS, 13 in 1:20-cv-01531-LPS) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham filed by Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 1/5/21. Associated Cases: 1:20-cv-01287-LPS et al. (ntl) |
| Jan 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:20-cv-01531-LPS, 10 in 1:20-cv-01599-LPS) MOTION for Pro Hac Vice Appearance of Attorney Kenneth S. Canfield, Attorney Edward D. Pergament, and Attorney Dmitry V. Shelhoff filed by Hetero Labs Limited Unit-V, Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd., Hetero USA, Inc., Honour Lab Ltd., Hetero Labs Ltd., Hetero Drugs Ltd. Signed by Judge Leonard P. Stark on 1/5/21. Associated Cases: 1:20-cv-01531-LPS, 1:20-cv-01599-LPS (ntl) |
| Jan 5, 2021 | 10 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kenneth S. Canfield, Attorney Edward D. Pergament, and Attorney Dmitry V. Shelhoff - filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd., Hetero Drugs Ltd., Hetero Labs Limited Unit-V, Hetero Labs Ltd., Hetero USA, Inc., Honour Lab Ltd.. (Dorsney, Kenneth) |
| Dec 31, 2020 | 9 | Motion for Leave to Appear Pro Hac Vice (17) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. (Mayo, Andrew) |
| Dec 2, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Nov 30, 2020 | 7 | Answer to Complaint (9) Docket Text: ANSWER to [1] Complaint, by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd..(Dorsney, Kenneth) |
| Nov 30, 2020 | 8 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biophore India Pharmaceuticals Private Ltd. for Zenara Pharma Private Ltd. filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth) |
| Nov 25, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (amf) |
| Nov 24, 2020 | 1 | Main Document (10) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Biophore India Pharmaceuticals Private Ltd. and Zenara Pharma Private Ltd. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number ADEDC-3353408.) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: # (1) Exhibits A-B, # (2) Civil Cover Sheet)(amf) |
| Nov 24, 2020 | 1 | Exhibits A-B (60) |
| Nov 24, 2020 | 1 | Civil Cover Sheet (5) |
| Nov 24, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf) |
| Nov 24, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/15/2020. Date of Expiration of Patent: 4/12/2026.Thirty Month Stay Deadline: 1/10/2023. (amf) |
| Nov 24, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE48,059. (amf) |
| Nov 24, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. - filed by Otsuka Pharmaceutical Co., Ltd. (amf) |
| Nov 24, 2020 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed - filed by H. Lundbeck A/S. (amf) |
| Nov 24, 2020 | 1 | Complaint* (1) |
